TITLE

High jejunal perforation complicating tuberculous abdominal cocoon: a rare presentation in immune-competent male patient

AUTHOR(S)
Bani-Hani, M. G.; Al-Nowfal, A.; Gould, S.
PUB. DATE
July 2009
SOURCE
Journal of Gastrointestinal Surgery;Jul2009, Vol. 13 Issue 7, p1373
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: Tuberculosis (TB) peritonitis is a rare presentation of TB that is typically insidious, presenting with systemic symptoms and nonspecific abdominal pain. In the majority of the cases, this leads to bowel obstruction and rarely causes abdominal cocoon. The disease process predominantly affects the small bowel with a tendency to involve the terminal ileum, leading to perforation on rare occasions.Methods: We are presenting a case report of multiple small-bowel perforations in immune-competent male patient complicating a TB cocoon and discuss clinical course and therapeutic options.Discussion: TB cocoon is a rare form of TB peritonitis presenting usually in the form of bowel obstruction. However, TB can cause multiple bowel perforations, particularly in children and immune-compromised patients. Such presentation carries a high rate of mortality. With the global increase in TB infections and the emergence of aggressive, multidrug-resistant strains, more severe manifestations are expected to increase. We presented a case of such severe acute manifestation on a background of insidious TB cocoon in a fit immune-competent male. Although primary repair of TB perforation is considered hazardous, it could not be avoided on this occasion. Nevertheless, proximal defunctioning jejunostomy and the early use of anti-TB drugs seemed to facilitate healing in such scenario.Conclusions: TB should be considered in all cases of atypical bowel perforations. Proximal jejunostomy and early use of anti-TB drugs can facilitate primary repair in aggressive TB infection with multiple bowel perforations.
ACCESSION #
44088806

 

Related Articles

  • Abdominal cocoon: clinical presentation, diagnosis, and management. Mohanty, Debajyoti; Jain, Bhupendra Kumar; Agrawal, Juhi; Gupta, Arun; Agrawal, Vivek // Journal of Gastrointestinal Surgery;Jun2009, Vol. 13 Issue 6, p1160 

    A 15-year-old girl presented with features suggestive of sub-acute intestinal obstruction (SAIO) with a palpable abdominal lump. Contrast-enhanced computed tomogram (CECT) abdomen revealed congregated small gut loops confined to a single area and encased in a thick membrane suggestive of...

  • Combination TB drug approved.  // FDA Consumer;Sep94, Vol. 28 Issue 7, p2 

    Comments on approval by the Food and Drug Administration (FDA) of Rifater, a product that combines three existing tuberculosis drugs into a single tablet. Why this fixed-dose product was developed.

  • tuberculostatic.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2385 

    A definition of the medical term "tuberculostatic," which refers to inhibiting the growth of tubercle bacillus, is presented.

  • High prevalence of resistance to second-line anti-TB drugs.  // Reactions Weekly;9/8/2012, Issue 1418, p4 

    The article reports on the Preserving Effective TB Treatment Study (PETTS) which reveals that the prevalence of resistance to second-line antituberculosis drugs is high.

  • Ethionamide.  // Reactions Weekly;7/6/2013, Issue 1460, p22 

    The article presents a case study of a 38-year-old man who developed gynaecomastia while receiving ethionamide and antituberculars for the treatment of pulmonary tuberculosis.

  • Are free anti-tuberculosis drugs enough? An empirical study from three cities in China. Shanquan Chen; Hui Zhang; Yao Pan; Qian Long; Li Xiang; Lan Yao; Lucas, Henry // Infectious Diseases of Poverty;10/28/2015, Vol. 4, p1 

    Background: Tuberculosis (TB) patients in China still face a number of barriers in seeking diagnosis and treatment. There is evidence that the economic burden on TB patients and their households discourages treatment compliance. Methods: A cross-sectional study was conducted in three cities of...

  • Treating TB today. King, Michalene A.; Tomasic, Diane M.; Moore, Amy Slugg // RN;Jun99, Vol. 62 Issue 6, p26 

    Discusses the management of tuberculosis in the United States. Infection control practices; Mode of transmission; Individuals at risk of infection; Screening of tuberculosis; Anti-tuberculosis drugs; Patient education.

  • In vivo veritas: The search for TB drug targets goes live. McKinney, John D. // Nature Medicine;Dec2000, Vol. 6 Issue 12, p1330 

    The term 'microbial persistence' describes a phenomenon whereby microorganisms which are drug-susceptible when tested outside the body are nevertheless capable of surviving within the body despite intensive therapy with the appropriate antimicrobial drug. In clinical practice this phenomenon...

  • Ethambutol/isoniazid/pyrazinamide/rifampicin.  // Reactions Weekly;5/5/2012, Issue 1400, p20 

    The article describes the case of a patient who developed paradoxical worsening of cutaneous lesions after receiving antitubercular therapy for miliary tuberculosis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics